RR Auction has announced that an Apple check signed by the company's co-founders Steve Jobs and Steve Wozniak fetched a whopping $2.4 million at auction this week. The check was for $500, meaning that ...

RTX (RTX) has been drawing attention after recent trading, with the stock last closing at US$203.50. That price sits alongside a reported US$88.6b in revenue and US$6.7b in net income. For investors ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What Mastercard’s latest ...

Did our AI summary help? IT major Cognizant Technology Solutions, on February 4, sought to calm investor concerns around artificial intelligence-led disruption after a sharp selloff wiped out nearly ...

Anthropic has just concluded a $30 billion Series G fundraising round, the company announced on Thursday. The company’s new value is $380 billion — a huge jump from its previous Series F valuation of ...

SEATTLE — The City of Seattle has settled the wrongful death lawsuit for Jaahnavi Kandula more than three years after the 23-year-old was hit and killed by a police officer in a crosswalk. "There’s a ...

Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

Sample rates are easy to browse online. Quick, convenient pre-qualification process. Average time to close is just under 20 days, faster than industry standard. What we don't like Home loans aren’t ...

Despite weaker-than-expected interim numbers, CSL maintains “ambitious” full-year guidance. But investors are sceptical Rhythm Biosciences enlists its first prescriber for its Colostat bowel cancer ...